Marta Sitges
Latest contributions
The continuum of valvular heart disease: a lifetime management approach
21 May 2026 – From EuroPCR 2026
This session offers a comprehensive perspective on valvular heart disease through the lens of lifetime management, highlighting the need for strategic planning across aortic, mitral, and tricuspid interventions, illustrating how treating one valve can influence the progression and management of others. Gain insights into optimal timing...
Tricuspid interventions: find the best candidate
20 May 2026 – From EuroPCR 2026
This session reviews the phenotypes of tricuspid regurgitation and their diagnostic pathways, emphasizing standardized and pragmatic diagnostic steps. It also addresses criteria for identifying optimal timing and candidates for tricuspid valve interventions.
PCR Fellowship Programmes: A new international stepping stone in PCR’s educational universe
19 May 2026
PCR has developed an independent educational framework to facilitate the worldwide training of the next generation of interventional cardiologists in host centres that are renowned for their expertise. This new initiative supports practitioners at all stages of their career – promoting professional growth, geographical mobility and cultural exchange.
From referral to discharge: European consensus on the TAVI care pathway
19 May 2026 – From EuroPCR 2026
Across Europe, TAVI programmes are under increasing pressure from rising demand, capacity limits and referral barriers. This EuroPCR 2026 session presents the European consensus on the TAVI care pathway and explores how data-driven, standardised approaches can optimise the patient journey from referral to discharge.
Bringing together clinicians,...
Outcomes in tricuspid valve intervention
19 May 2026 – From EuroPCR 2026
This session reviews contemporary clinical outcomes of tricuspid valve interventions. Topics include interim results from the Cardiovalve replacement system trial, the impact of atrial fibrillation on tricuspid TEER, residual regurgitation implications, afterload mismatch post-intervention, and long-term bioprosthetic valve durability.
Mitral Valve Regurgitation – From Assessment to Referral
10 Apr 2026
Download a guide that serves as a valuable practical reference, from the echocardiographic assessment to the referral and follow-up of your patients with mitral regurgitation.
Atrial mitral and tricuspid regurgitation
09 Apr 2026
M. Sitges, M. Adamo, P. Lurz, D. Muraru and T. De Potter guide you through understanding combined mitral regurgitation and tricuspid regurgitation in patients with atrial fibrillation.
From GDMT to TEER: management of secondary mitral regurgitation and the timing of transcatheter intervention
18 Nov 2025 – From PCR London Valves 2025
Delve into the comprehensive management of secondary mitral regurgitation, from guideline-directed medical therapy (GDMT) to transcatheter edge-to-edge repair (TEER). This session elucidates the pathophysiology of atrial and ventricular secondary mitral regurgitation, explores optimized heart failure treatments, and reviews the latest evidence on TEER as a therapeutic...
Learning from lived experience and contemporary evidence: shaping the treatment of women with heart valve disease
17 Nov 2025 – From PCR London Valves 2025
This session provides an in-depth exploration of the lived experiences of women with valvular heart disease, emphasizing the unique challenges in detection, diagnosis, treatment, and follow-up. It integrates contemporary evidence and the forthcoming 2025 ESC/EACTS guidelines to offer practice-ready strategies tailored to the management of valvular...
How do we meet the needs of women with heart valve disease?
27 Mar 2026 – From PCR London Valves 2025
In this interview, Ellen Ross and Marta Sitges discuss a recent initiative from Global Heart Hub - a patient association - which examined the realities faced by women living with heart valve disease. They outline the gaps identified, the call to action that followed, and how...
Procedural imaging for tricuspid valve interventions
16 Nov 2025 – From PCR London Valves 2025
Master procedural imaging techniques essential for tricuspid valve interventions, including TOE views, multi-phase reconstruction, and 3D/4D steering. This session also covers quantification of residual tricuspid regurgitation post-device deployment and the appropriate use of intracardiac echocardiography.
Mitral TEER - LIVE Case
16 Nov 2025 – From PCR London Valves 2025
Watch this live case followed by a recorded case, regarding a 75-year-old male with type 2 DM, permanent AF, and severe LV dysfunction (30%), with a history of RCA PCI one month earlier and three hospitalizations for heart failure, presented with severe secondary mitral and tricuspid...
How will the new valvular guidelines impact my tricuspid programme?
16 Oct 2025
Watch this replay with F. Maisano, J. Dreyfus, J. Hausleiter and M. Sitges to get familiar with new recommendations regarding the treatment of the tricuspid valve and so much more!
Echocardiographic guide on tricuspid valve interventions
05 Sep 2025
Master anatomy, imaging views, and procedural guidance with this comprehensive echocardiographic reference for tricuspid interventions.
Learn the latest from the PCR Tricuspid Focus Group!
Launch the video to hear Marianna Adamo and Marta Sitges share how they and Julien Dreyfus strengthened the Leadership team at the end of last year, bringing welcome support to founders Francesco Maisano and Fabien Praz.
They explain their individual roles among the PCR Tricuspid Focus Group;...
Tricuspid regurgitation and heart failure with preserved ejection fraction
11 Jun 2025
Watch the replay of this webinar with M. Adamo, M. Metra, K-P. Kresoja, P. Lurz, P. Ponikowski and M. Sitges and learn about mechanisms and risk factors for HFpEF and TR, and so much more!
The impact of paravalvular leak, permanent pacemaker implantation and the planning for reinterventions on lifetime management in TAVI patients
22 May 2025 – From EuroPCR 2025
How do paravalvular leak, pacemaker implantation and reintervention planning shape lifetime outcomes in TAVI patients?
This session examines these crucial aspects through the case of a 77-year-old male with bicuspid aortic valve stenosis, HFpEF and multiple comorbidities, including diabetes, obesity and sleep apnoea.
Follow the discussion to understand...
Assessment and management of patients with multivalvular disease involving the tricuspid valve
22 May 2025 – From EuroPCR 2025
Gain expertise on managing multivalvular disease involving the tricuspid valve by understanding diagnostic challenges, intervention indications, and associated pathophysiological factors. This session includes complex case studies focusing on combined valvular lesions and guideline limitations.
Mitral and tricuspid hotline: long-term outcomes
20 May 2025 – From EuroPCR 2025
Review long-term outcomes of transcatheter edge-to-edge repair (TEER) for mitral and tricuspid valve disease in this session. Highlights include pivotal trial results, mortality risk prediction tools, management of procedural failures, and real-world data, providing comprehensive insights into patient prognosis and therapeutic impact.
Pioneering innovation in the treatment of mitral and tricuspid regurgitation
20 May 2025 – From EuroPCR 2025
This interventional session explores therapeutic strategies for mitral and tricuspid regurgitation, focusing on the clinical decision-making process between repair and replacement. Through two clinical cases, a 78-year-old male patient with severe degenerative mitral regurgitation and an 88-year-old female patient with atrial functional mitral regurgitation, experts review available...
Advancing imaging and intervention strategies for mitral valve disease
31 Jan 2025 – From PCR Imaging Valves Madrid 2025
Explore the latest imaging techniques for transcatheter mitral valve interventions, including patient screening, device selection, and strategies for challenging anatomies. Gain insights into TEER and transcatheter mitral valve replacement to optimize patient outcomes.
Mastering mitral valve disease: diagnosis, management, and intervention
31 Jan 2025 – From PCR Imaging Valves Madrid 2025
Dive into this comprehensive session on mitral valve disease, covering key aspects of diagnosis, classification, assessment, management, and patient selection for transcatheter intervention. Gain in-depth knowledge through real-world case studies and multidisciplinary team discussions, equipping you with essential skills to optimize patient care.
Advanced imaging in tricuspid TEER - LIVE case
26 Nov 2024 – From PCR London Valves 2024
Watch a LIVE case followed by a recorded case on how to use imaging in tricuspid TEER:
- A 64-year-old male with a history of CABG and COPD, ICD implantation (2013) mitraclip (2018) and poor LV function (25%), presented a torrential functional tricuspid regurgitation. The operators implanted 2...
Tricuspid transcatheter edge-to-edge repair - The fundamentals
25 Nov 2024 – From PCR London Valves 2024
Ready to dive into tricuspid transcatheter edge-to-edge repair (TEER)? This video breaks down the procedure by exploring real-world cases and key techniques.
Through practical case presentations, you'll gain insights into the anatomical criteria that determine suitability for TEER, the importance of imaging and haemodynamic assessments and the...
Mitral TEER - Advanced skills (challenging anatomy - when, why and how?)
24 Nov 2024 – From PCR London Valves 2024
Curious about how to tackle complex mitral valve anatomies with transcatheter edge-to-edge repair (TEER)? This video dives straight into advanced techniques for challenging cases, delivering expert insights on expanding indications, optimal patient selection and precise procedural strategies.
Through real-world case presentations, you’ll learn the “when, why, and...
Asymptomatic severe aortic stenosis: Will these trials change my practice?
16 May 2024 – From EuroPCR 2024
This session, in collaboration with Partners in Learning, explores the emerging evidence on the use of transcatheter aortic valve implantation (TAVI) in patients with asymptomatic severe aortic stenosis. It covers data from registries and randomized controlled trials, the current guideline recommendations, and the potential impact of...
Pacemaker lead and the tricuspid valve: navigating challenges for optimal care
16 May 2024 – From EuroPCR 2024
This session focuses on the complex interplay between pacemaker leads and the tricuspid valve, addressing the anatomical interactions, procedural challenges, and alternative pacing strategies. Attendees will gain a better understanding of the impact of pacemaker leads on tricuspid regurgitation, the techniques for lead implantation and extraction,...
Transformative imaging in the clinical pathway of transcatheter tricuspid valve interventions
16 May 2024 – From EuroPCR 2024
Explore this EuroPCR 2024 session for a comprehensive understanding of the imaging pathway in transcatheter tricuspid valve interventions, including diagnosis, therapy, and post-procedural follow-up, discover innovative, transformative imaging techniques such as 4D intracardiac echocardiography and dual-source photon-counting CT, and learn how these innovations can be applied in...
Valvular and structural interventions
16 May 2024 – From EuroPCR 2024
This session features presentations and discussions on various novel transcatheter technologies for valvular and structural heart interventions. It includes a novel transcatheter tricuspid repair technology, a new endovascular aortic root and total arch stent-graft replacement system, a novel self-expandable transcatheter aortic valve, and a transcatheter mitral...
Heterotopic tricuspid valves: to who, when and how?
15 May 2024 – From EuroPCR 2024
Watch this session to gain comprehensive insights into the use, safety, and efficacy of heterotopic tricuspid valves. Learn to identify ideal candidates with severe tricuspid regurgitation, understand key procedural factors for successful implantation, and receive tips on valve systems and anatomy. The session also includes...
